CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.800
  • 0.0000.00%
15min DelayMarket Closed Mar 24 16:00 ET
42.42MMarket Cap-0.76P/E (TTM)

Helix BioPharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
43.24%1.29M
27.32%1.59M
46.05%9.24M
145.89%5.26M
34.44%1.82M
-27.02%902K
-21.01%1.25M
4.74%6.33M
91.93%2.14M
4.15%1.36M
Selling and administrative expenses
-69.44%22K
-83.33%28K
761.20%2.58M
1,497.18%2.27M
-8.11%68K
-1.37%72K
1,192.31%168K
-49.75%299K
97.22%142K
-36.75%74K
-General and administrative expense
-69.44%22K
-83.33%28K
761.20%2.58M
1,497.18%2.27M
-8.11%68K
-1.37%72K
1,192.31%168K
-49.75%299K
97.22%142K
-36.75%74K
Research and development costs
24.16%848K
39.20%1.32M
13.18%5.98M
53.85%2.86M
36.99%1.49M
-33.62%683K
-27.00%949K
16.22%5.28M
122.10%1.86M
15.44%1.08M
Other operating expenses
187.07%422K
81.48%245K
-7.91%687K
-3.60%134K
36.36%270K
9.70%147K
-50.37%135K
-17.20%746K
-32.52%139K
-19.51%198K
Operating profit
-43.24%-1.29M
-27.32%-1.59M
-46.05%-9.24M
-145.89%-5.26M
-34.44%-1.82M
27.02%-902K
21.01%-1.25M
-4.74%-6.33M
-91.93%-2.14M
-4.15%-1.36M
Net non-operating interest income (expenses)
-120.00%-1K
-40.00%6K
-27.27%24K
200.00%9K
0
-64.29%5K
66.67%10K
335.71%33K
400.00%3K
600.00%10K
Non-operating interest income
-66.67%2K
-46.15%7K
-34.04%31K
66.67%10K
-85.71%2K
-64.71%6K
30.00%13K
1,075.00%47K
50.00%6K
--14K
Non-operating interest expense
200.00%3K
-66.67%1K
-50.00%7K
-66.67%1K
-50.00%2K
-66.67%1K
-25.00%3K
-22.22%14K
-40.00%3K
100.00%4K
Other net income (expenses)
-1,540.00%-82K
2,200.00%252K
-1,733.33%-49K
-47.06%-25K
-188.89%-8K
-113.51%-5K
53.85%-12K
100.59%3K
93.73%-17K
121.95%9K
Gain on sale of security
-1,800.00%-95K
-83.33%-22K
-2,350.00%-49K
-47.06%-25K
-300.00%-8K
-113.51%-5K
53.85%-12K
77.78%-2K
-666.67%-17K
-63.64%4K
Special income (charges)
--13K
--274K
--0
--0
--0
--0
--0
--5K
--0
--5K
-Less:Other special charges
----
---268K
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
--13K
--6K
--0
--0
--0
--0
--0
--5K
--0
--5K
Income before tax
-52.44%-1.38M
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.17%-6.29M
-55.30%-2.15M
0.59%-1.34M
Income tax
Earnings from equity interest net of tax
Net income
-52.44%-1.38M
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
Net income continuous operations
-52.44%-1.38M
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
Noncontrolling interests
Net income attributable to the company
-52.44%-1.38M
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-52.44%-1.38M
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
Diluted earnings per share
-50.00%-0.15
0.00%-0.15
-31.25%-1.05
-99.96%-0.1077
14.10%-0.043
-100.00%-0.1
-200.00%-0.15
-300.00%-0.8
-0.0538
0.00%-0.05
Basic earnings per share
-50.00%-0.15
0.00%-0.15
-31.25%-1.05
-99.96%-0.1077
14.10%-0.043
-100.00%-0.1
-200.00%-0.15
-300.00%-0.8
-0.0538
0.00%-0.05
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 43.24%1.29M27.32%1.59M46.05%9.24M145.89%5.26M34.44%1.82M-27.02%902K-21.01%1.25M4.74%6.33M91.93%2.14M4.15%1.36M
Selling and administrative expenses -69.44%22K-83.33%28K761.20%2.58M1,497.18%2.27M-8.11%68K-1.37%72K1,192.31%168K-49.75%299K97.22%142K-36.75%74K
-General and administrative expense -69.44%22K-83.33%28K761.20%2.58M1,497.18%2.27M-8.11%68K-1.37%72K1,192.31%168K-49.75%299K97.22%142K-36.75%74K
Research and development costs 24.16%848K39.20%1.32M13.18%5.98M53.85%2.86M36.99%1.49M-33.62%683K-27.00%949K16.22%5.28M122.10%1.86M15.44%1.08M
Other operating expenses 187.07%422K81.48%245K-7.91%687K-3.60%134K36.36%270K9.70%147K-50.37%135K-17.20%746K-32.52%139K-19.51%198K
Operating profit -43.24%-1.29M-27.32%-1.59M-46.05%-9.24M-145.89%-5.26M-34.44%-1.82M27.02%-902K21.01%-1.25M-4.74%-6.33M-91.93%-2.14M-4.15%-1.36M
Net non-operating interest income (expenses) -120.00%-1K-40.00%6K-27.27%24K200.00%9K0-64.29%5K66.67%10K335.71%33K400.00%3K600.00%10K
Non-operating interest income -66.67%2K-46.15%7K-34.04%31K66.67%10K-85.71%2K-64.71%6K30.00%13K1,075.00%47K50.00%6K--14K
Non-operating interest expense 200.00%3K-66.67%1K-50.00%7K-66.67%1K-50.00%2K-66.67%1K-25.00%3K-22.22%14K-40.00%3K100.00%4K
Other net income (expenses) -1,540.00%-82K2,200.00%252K-1,733.33%-49K-47.06%-25K-188.89%-8K-113.51%-5K53.85%-12K100.59%3K93.73%-17K121.95%9K
Gain on sale of security -1,800.00%-95K-83.33%-22K-2,350.00%-49K-47.06%-25K-300.00%-8K-113.51%-5K53.85%-12K77.78%-2K-666.67%-17K-63.64%4K
Special income (charges) --13K--274K--0--0--0--0--0--5K--0--5K
-Less:Other special charges -------268K--------------------------------
-Gain on sale of property,plant,equipment --13K--6K--0--0--0--0--0--5K--0--5K
Income before tax -52.44%-1.38M-6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.87%-1.25M4.17%-6.29M-55.30%-2.15M0.59%-1.34M
Income tax
Earnings from equity interest net of tax
Net income -52.44%-1.38M-6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.87%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M
Net income continuous operations -52.44%-1.38M-6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.87%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M
Noncontrolling interests
Net income attributable to the company -52.44%-1.38M-6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -52.44%-1.38M-6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M
Diluted earnings per share -50.00%-0.150.00%-0.15-31.25%-1.05-99.96%-0.107714.10%-0.043-100.00%-0.1-200.00%-0.15-300.00%-0.8-0.05380.00%-0.05
Basic earnings per share -50.00%-0.150.00%-0.15-31.25%-1.05-99.96%-0.107714.10%-0.043-100.00%-0.1-200.00%-0.15-300.00%-0.8-0.05380.00%-0.05
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.

Unlock Now